Oramed Pharmaceuticals (ORMP) Institutional Ownership $2.26 -0.04 (-1.74%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Oramed Pharmaceuticals (NASDAQ:ORMP)CurrentInstitutional OwnershipPercentage12.73%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$5.72MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$2.53M Get ORMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ORMP Institutional Buying and Selling by Quarter Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Oramed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 XTX Topco Ltd24,716$60K0.0%+59.7%0.061% 11/15/2024 Murchinson Ltd.1,708,879$4.17M1.1%+0.5%4.239% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.111,519$272K0.0%N/A0.274% 11/5/2024 BML Capital Management LLC2,186,191$5.33M3.1%+62.1%5.362% 8/16/2024 Murchinson Ltd.1,699,990$4.37M0.7%+23.2%4.184% 8/14/2024 Squarepoint Ops LLC81,758$210K0.0%-8.3%0.201% Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/14/2024 Murchinson Ltd.874,992$2.25M0.4%-36.6%2.154% 8/12/2024 XTX Topco Ltd15,474$40K0.0%N/A0.038% 8/9/2024 Renaissance Technologies LLC230,800$593K0.0%+89.0%0.568% 8/9/2024 Dimensional Fund Advisors LP31,470$81K0.0%+52.1%0.077% 5/20/2024Virtu Financial LLC23,165$68K0.0%N/A0.057% 5/16/2024 Murchinson Ltd.1,379,495$4.03M0.3%+31.4%3.395% 4/24/2024 Assenagon Asset Management S.A.18,659$54K0.0%N/A0.046% 4/23/2024 BML Capital Management LLC844,496$2.47M1.6%-33.1%2.084% 1/30/2024 BML Capital Management LLC1,261,559$2.91M2.2%+61.5%3.127% 11/13/2023 Algert Global LLC14,680$38K0.0%N/A0.036% 11/13/2023 Rathbones Group PLC289,803$756K0.0%N/A0.718% 11/7/2023 Barclays PLC18,406$47K0.0%+39.0%0.046% 11/6/2023 N.E.W. Advisory Services LLC12,960$34K0.0%N/A0.032% 10/23/2023 BML Capital Management LLC781,292$2.04M1.9%-8.1%1.940% 9/21/2023 Barclays PLC13,239$47K0.0%-35.9%0.033% 8/7/2023 Acadian Asset Management LLC31,736$113K0.0%N/A0.079% 7/26/2023 Glass Jacobson Investment Advisors llc12,255$44K0.0%N/A0.031% 7/24/2023 BML Capital Management LLC850,000$3.04M2.7%-37.3%2.123% 5/12/2023 Corsair Capital Management L.P.47,256$103K0.0%N/A0.119% 4/18/2023ETF Managers Group LLC68,940$150K0.0%N/A0.173% 4/14/2023 BML Capital Management LLC1,355,925$2.96M2.6%N/A3.409% 2/14/2023 683 Capital Management LLC20,537$247K0.0%N/A0.052% 2/13/2023 GSA Capital Partners LLP46,039$554K0.1%N/A0.118% 2/9/2023 Landscape Capital Management L.L.C.26,220$315K0.0%N/A0.067% 2/9/2023 Citigroup Inc.65,890$793K0.0%+115.0%0.168% 2/8/2023 Belpointe Asset Management LLC29,900$360K0.0%N/A0.076% 2/8/2023 Russell Investments Group Ltd.56,516$680K0.0%N/A0.144% 2/6/2023 Glass Jacobson Investment Advisors llc9,350$112K0.1%N/A0.024% 2/1/2023Private Portfolio Partners LLC53,600$645K0.2%-20.5%0.137% 2/1/2023 Janney Montgomery Scott LLC12,379$149K0.0%N/A0.032% 1/26/2023 Calamos Advisors LLC14,746$177K0.0%N/A0.038% 1/25/2023 Lindbrook Capital LLC383,351$4.61M0.6%N/A0.980% 1/18/2023 Private Advisor Group LLC11,794$142K0.0%N/A0.030% 11/15/2022ETF Managers Group LLC94,493$612K0.0%+8.2%0.242% When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away!11/14/2022 Cubist Systematic Strategies LLC117,477$761K0.0%+66.1%0.303% 11/14/2022Ergoteles LLC24,149$156K0.0%-89.3%0.062% 11/10/2022 Phoenix Holdings Ltd.13,634$89K0.0%-73.2%0.035% 11/7/2022Virtu Financial LLC21,526$139K0.0%-19.3%0.055% 11/7/2022Private Portfolio Partners LLC67,400$437K0.1%+24.8%0.174% 11/3/2022 Barclays PLC21,543$140K0.0%+8.7%0.055% 10/31/2022 SG Americas Securities LLC10,370$67K0.0%-77.7%0.027% 10/21/2022Morgan Jess S & Co. Inc.366,401$2.37M2.1%+16.2%0.944% 10/17/2022 Cambridge Investment Research Advisors Inc.14,184$92K0.0%+26.8%0.037% 8/15/2022 Laurion Capital Management LP12,393$57K0.0%N/A0.032% 8/13/2022Virtu Financial LLC26,661$122K0.0%N/A0.069% 8/11/2022 Bank of Montreal Can249,200$1.35M0.0%N/A0.646% 8/8/2022 Oppenheimer & Co. Inc.50,000$229K0.0%+5.4%0.130% 8/2/2022Private Portfolio Partners LLC54,010$247K0.1%+27.8%0.140% 7/29/2022 SG Americas Securities LLC46,532$213K0.0%N/A0.121% 7/21/2022 Belvedere Trading LLC40,690$343K0.0%N/A0.106% 7/19/2022Commonwealth Equity Services LLC29,514$135K0.0%+7.1%0.077% 7/18/2022Morgan Jess S & Co. Inc.315,301$1.44M1.5%+8.5%0.818% 7/13/2022 Cambridge Investment Research Advisors Inc.11,184$51K0.0%N/A0.029% 6/30/2022 Amalgamated Bank6,457$56K0.0%N/A0.017% 5/16/2022Morgan Jess S & Co. Inc.290,501$2.51M1.8%+34.9%0.759% 5/12/2022Private Portfolio Partners LLC42,250$365K0.1%N/A0.110% 5/12/2022 Oppenheimer & Co. Inc.47,450$410K0.0%+18.6%0.124% 5/10/2022 Phoenix Holdings Ltd.28,155$244K0.0%-10.1%0.074% 5/9/2022 Rossmore Private Capital40,661$352K0.1%-21.8%0.106% 5/9/2022 Qube Research & Technologies Ltd56,348$487K0.0%-13.0%0.147% 5/5/2022 Russell Investments Group Ltd.43,013$371K0.0%-55.7%0.112% 5/3/2022 Calamos Advisors LLC38,071$330K0.0%-65.9%0.099% 4/25/2022 Assenagon Asset Management S.A.385,413$3.33M0.0%N/A1.007% 4/21/2022 Strs Ohio5,400$46K0.0%-41.9%0.014% 3/3/2022 Walleye Capital LLC36,740$525K0.0%N/A0.096% 2/14/2022 Point72 Hong Kong Ltd2,132$30K0.0%N/A0.006% 2/14/2022ETF Managers Group LLC53,153$729K0.0%+6.5%0.139% 2/14/2022 Rockefeller Capital Management L.P.4,000$57K0.0%N/A0.010% 2/11/2022 Renaissance Technologies LLC203,200$2.90M0.0%N/A0.531% 2/10/2022 Qube Research & Technologies Ltd64,799$925K0.0%N/A0.169% 2/10/2022 OLD Mission Capital LLC38,691$553K0.0%N/A0.101% 2/10/2022 HighTower Advisors LLC14,000$199K0.0%-50.0%0.037% 2/10/2022 Connor Clark & Lunn Investment Management Ltd.50,786$725K0.0%+96.4%0.133% 2/9/2022 BNP Paribas Arbitrage SA20,266$289K0.0%+275.9%0.053% 2/9/2022 UMB Bank N A MO8,080$116K0.0%N/A0.021% 2/8/2022 Swiss National Bank64,400$920K0.0%N/A0.168% 2/8/2022 Northern Trust Corp243,125$3.47M0.0%+7.7%0.635% 2/7/2022 Victory Capital Management Inc.13,310$190K0.0%N/A0.035% 2/7/2022 SG Americas Securities LLC8,631$123K0.0%-36.3%0.023% 2/7/2022 Phoenix Holdings Ltd.31,328$439K0.0%+9.5%0.082% 2/7/2022 Rossmore Private Capital52,004$743K0.1%+10.6%0.136% 2/3/2022 Advisor Group Holdings Inc.26,267$375K0.0%+49.5%0.069% 2/2/2022 New York State Common Retirement Fund22,545$322K0.0%+25.5%0.059% 2/2/2022 Oppenheimer & Co. Inc.40,000$571K0.0%+14.9%0.104% When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away!2/1/2022 Zurcher Kantonalbank Zurich Cantonalbank7,706$110K0.0%N/A0.020% 2/1/2022 Calamos Advisors LLC111,519$1.59M0.0%-15.6%0.291% 2/1/2022 Qube Research & Technologies Ltd64,799$925K0.0%N/A0.169% 1/28/2022 Allspring Global Investments Holdings LLC68,317$975K0.0%N/A0.178% 1/27/2022 Janney Montgomery Scott LLC23,260$332K0.0%+13.6%0.061% 1/27/2022Morgan Jess S & Co. Inc.215,401$3.08M1.9%+0.7%0.563% 1/21/2022 Russell Investments Group Ltd.97,110$1.39M0.0%-5.6%0.254% 12/8/2021 Moors & Cabot Inc.435,000$443K0.0%N/A1.142% 11/17/2021 Altium Capital Management LP493,384$12.63M2.8%N/A1.517% 11/15/2021 Man Group plc37,285$820K0.0%+170.2%0.115% (Data available from 1/1/2016 forward) ORMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ORMP shares? During the previous two years, 28 institutional investors and hedge funds held shares of Oramed Pharmaceuticals. The most heavily invested institutionals were BML Capital Management LLC ($5.33M), Lindbrook Capital LLC ($4.61M), Murchinson Ltd. ($4.17M), Citigroup Inc. ($793K), Rathbones Group PLC ($756K), Russell Investments Group Ltd. ($680K), and Private Portfolio Partners LLC ($645K).Learn more on ORMP's institutional investors. What percentage of Oramed Pharmaceuticals stock is owned by institutional investors? 12.73% of Oramed Pharmaceuticals stock is owned by institutional investors. Learn more on ORMP's institutional investor holdings. Which institutional investors have been buying Oramed Pharmaceuticals stock? Of the 26 institutional investors that purchased Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($2.67M), Murchinson Ltd. ($658.88K), Lindbrook Capital LLC ($383.35K), Rathbones Group PLC ($289.80K), Connor Clark & Lunn Investment Management Ltd. ($111.52K), Renaissance Technologies LLC ($108.70K), and ETF Managers Group LLC ($68.94K). How much institutional buying is happening at Oramed Pharmaceuticals? Institutional investors have bought a total of 4,758,632 shares in the last 24 months. This purchase volume represents approximately $17.70M in transactions. Which Oramed Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Oramed Pharmaceuticals stock in the last 24 months: BML Capital Management LLC ($991.70K), Murchinson Ltd. ($504.50K), Private Portfolio Partners LLC ($13.80K), Barclays PLC ($7.41K), and Squarepoint Ops LLC ($7.37K). How much institutional selling is happening at Oramed Pharmaceuticals? Institutional investors have sold a total of 1,524,776 shares in the last 24 months. This volume of shares sold represents approximately $4.72M in transactions. Related Companies Valneva Institutional Ownership Amylyx Pharmaceuticals Institutional Ownership Ginkgo Bioworks Institutional Ownership Alector Institutional Ownership Q32 Bio Institutional Ownership Contineum Therapeutics Institutional Ownership Kamada Institutional Ownership Alpha Teknova Institutional Ownership biote Institutional Ownership Cryoport Institutional Ownership This page (NASDAQ:ORMP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
